Top accelerator startups

Startups14,448Programs29

14,448 startups · 29 programs

Matrubials

Active · Developing milk-inspired therapeutics for infectious diseases

WebsiteYC profile

Why it ranks

How the rank works
8signal of 100 · rising 2
  • went through YCProgram · this site+4
  • team of 4Team size · YC's directory+3.6

A sum of public facts, not a judgement and not investment advice.

Competitors

OtherInactiveFelix BiotechnologyShared: antimicrobial resistance, therapeutics, drug discovery and deliveryYC W20San FranciscoStartup →AIBrown FoodsShared: human milk, infantYC W22BostonStartup →AIAmprologixShared: antimicrobial resistance, economicMassChallenge Switzerland 2025United KingdomStartup →AIGenoTwinShared: infectious disease, address, challengePlug and PlayUnited StatesStartup →
Companies closest to Matrubials
Company
Felix BiotechnologyShared: antimicrobial resistance, therapeutics, drug discovery and deliveryYC W20InactiveOther
Brown FoodsShared: human milk, infantYC W22ActiveAI
AmprologixShared: antimicrobial resistance, economicMassChallenge Switzerland 2025Not statedAI
GenoTwinShared: infectious disease, address, challengePlug and Play Not statedAI

Adjacent

OtherPublicLucira HealthShared: infectious disease, developingYC W15EmeryvilleStartup →OtherSabiadShared: bacterial infection, therapeutic, treatmentPlug and PlayNetherlandsStartup →OtherTotality BiosciencesShared: human milkMassChallenge Switzerland and UK 2026United StatesStartup →AIHarmonic DiscoveryShared: ai-powered drug discovery, therapeutic, diseaseYC S21New York CityStartup →AIEvolvere BioSciencesShared: ai-powered drug discovery, therapeutics, pathogenicYC S24OxfordStartup →
Companies next to Matrubials
Company
Lucira HealthShared: infectious disease, developingYC W15PublicOther
SabiadShared: bacterial infection, therapeutic, treatmentPlug and Play Not statedOther
Totality BiosciencesShared: human milkMassChallenge Switzerland and UK 2026Not statedOther
Harmonic DiscoveryShared: ai-powered drug discovery, therapeutic, diseaseYC S21ActiveAI
Evolvere BioSciencesShared: ai-powered drug discovery, therapeutics, pathogenicYC S24ActiveAI

Also from S21 in AI

All of S21
AIAdaptyvWe're building fully automated labs for protein engineeringYC S21LausanneStartup →AICellChorusThe dynamic single-cell analysis companyYC S21HoustonStartup →AIOutput LabsThe foundation for the next era of scienceYC S21New York CityStartup →AIParallel BioUsing the immune system to cure diseaseYC S21San FranciscoStartup →AIInactiveRuth HealthTelehealth hub for pregnant people 🧡YC S21New York CityStartup →AISafeBeatFirst ECG AI to go beyond diagnostics and recommend treatmentYC S21San FranciscoStartup →
Company
AdaptyvWe're building fully automated labs for protein engineeringteam of 25hiringActiveAI
CellChorusThe dynamic single-cell analysis companyteam of 4ActiveAI
Output LabsThe foundation for the next era of scienceteam of 10hiringActiveAI
Parallel BioUsing the immune system to cure diseaseteam of 20hiringActiveAI
Ruth HealthTelehealth hub for pregnant people 🧡team of 8InactiveAI
SafeBeatFirst ECG AI to go beyond diagnostics and recommend treatmentteam of 9hiringActiveAI

About Matrubials

Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk can be developed into therapeutics geared towards all-age diseases. Our first indication is bacterial vaginosis, a bacterial dysbiosis related inflammation that results in recurrent infections, disruption of homeostasis and long-term clinical complications in women of reproductive age, including but not limited to preterm births, fertility issues and increased rates of STDs. Our next inflection point is the evaluation of rapidly acting and selective candidate peptides in pre-clinical host impact and early safety studies, which can aid clinical and portfolio development towards topical applications.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
AI
Team size
4
Location
Davis, CA, USA
Checked
13h ago

YC tags: AI-powered Drug Discovery, Women's Health, Therapeutics

Matrubials in S21: 391 companies, 34% AI

Matrubials: questions

Which YC batch was Matrubials in?

Matrubials was in Y Combinator's Summer 2021 batch (S21).

Is Matrubials still active?

Y Combinator lists Matrubials as active.

Where is Matrubials based?

Matrubials lists Davis, CA, USA as its location on YC's directory.